21.03.2016 Vita 34 AG  DE000A0BL849

DGAP-Adhoc: Vita 34 AG increases Earnings per Share by 81 percent to EUR 0.67 and attains an EBITDA Margin of 27.5 percent


 
Vita 34 AG / Key word(s): Preliminary Results 21.03.2016 18:58 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Vita 34 AG increases Earnings per Share by 81 percent to EUR 0.67 and attains an EBITDA Margin of 27.5 percent Leipzig, March 21, 2016 - Vita 34 AG (WKN A0BL84) is publishing figures on fiscal year 2015 in advance. In fiscal year 2015 Vita 34 increased total operating revenues by 22.1 percent to EUR 18.5 million (2014: EUR 15.2 million). The period result increased to EUR 1.7 million in the reporting period (2014: EUR 1.0 million), which equates to earnings per share of EUR 0.67. The increase as compared with the previous year (2014: EUR 0.37) was, therefore 81.1 percent. Earnings before interest and taxes (EBIT) of EUR 1.6 million were at the prior year's level (2014: EUR 1.7 million). The earnings before interest, taxes, depreciation and amortization (EBITDA) rose to EUR 3.9 million (2014: EUR 2.8 million), which is equivalent to an EBITDA margin of 27.5 percent (2014: 20.1 percent). Consequently, Vita 34 has exceeded its own EBITDA forecast for fiscal year 2015 significantly, which had originally foreseen EBITDA at the prior year's level. Company revenues increased to EUR 14.2 million (2014: EUR 13.8 million) based on the product VitaPlusNabelschnur [VitaPlusCord], as well as acquisitions completed in 2015. Thus, the company exceeded prognoses set for fiscal year 2015. Other operating income increased to EUR 4.3 million, following EUR 1.7 million in the prior year's period. This development can be traced back to the profit effects from the initial consolidation of the acquisitions made. The Management Board and the Supervisory Board have resolved, to propose an increase of the dividend payment by 6.7 percent to EUR 0.16 per share to the Annual General Meeting. Vita 34 AG will publish the final figures for the 2015 reporting period, as well as the forecast for fiscal year 2016 with the Annual Report 2015 on March 30th, 2016. Additional information: ISIN: DE000A0BL849 WKN: A0BL84 Ticker symbol: V3V Market segment: Regulated Market (Prime Standard) of the Frankfurt Stock Exchange Vita 34 AG Deutscher Platz 5 04103 Leipzig Germany END OF THE AD-HOC NOTICE 21.03.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Vita 34 AG Deutscher Platz 5a 04103 Leipzig Germany Phone: +49(0341)48792-40 Fax: +49(0341)48792-39 E-mail: [email protected] Internet: www.vita34.de ISIN: DE000A0BL849 WKN: A0BL84 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 19,19 20,41 19,93 20,07 28,42 68,94 76,80
EBITDA1,2 1,85 4,72 5,43 5,34 0,81 -3,56 4,00
EBITDA-Marge3 9,64 23,13 27,25 26,61 2,85 -5,16
EBIT1,4 0,14 2,63 2,45 2,38 -3,07 -27,28 -4,65
EBIT-Marge5 0,73 12,89 12,29 11,86 -10,80 -39,57 -6,06
Jahresüberschuss1 -0,33 0,83 0,72 1,50 -3,93 -27,38 -5,20
Netto-Marge6 -1,72 4,07 3,61 7,47 -13,83 -39,72 -6,77
Cashflow1,7 1,53 4,60 6,32 3,98 2,73 -4,49 0,00
Ergebnis je Aktie8 -0,09 0,20 0,18 0,37 -0,63 -1,71 -0,29
Dividende8 0,16 0,16 0,00 0,00 0,00 0,00 0,16
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2022 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Vita 34
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A0BL84 4,500 Halten 79,38
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
17,31 25,42 0,68 -64,29
KBV KCV KUV EV/EBITDA
7,29 - 1,03 20,10
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 28.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
31.05.2024 30.08.2024 22.11.2024 30.04.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-5,36% -6,48% -14,12% -33,43%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Vita 34 AG  ISIN: DE000A0BL849 können Sie bei EQS abrufen


Biotechnologie , A0BL84 , V3V , XETR:V3V